By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys announced today the completion of its merger with Symyx, following approval by both companies' shareholders.

The completion of the merger follows the satisfaction of certain conditions and shareholder meetings held on Wednesday by Accelrys and Symyx to vote on the merger, under which terms Symyx shareholders will receive 0.7802 shares of Accelrys stock for each share of Symyx they own.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.